RecallDepth
Class II Terminated

Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count bottle, NDC# 68001-178-00; b) 500-count bottle; NDC# 68001-178-03 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. For BluePoint Laboratories

This recall has been terminated (originally issued May 31, 2023).

Company
Amerisource Health Services Llc
Recall Initiated
March 17, 2023
Posted
May 31, 2023
Recall Number
D-0758-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
105,361 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Distribution

Nationwide USA

Lot / Code Info

Batches a)P2003493, EXP 05/31/2023; P2100120, EXP 11/30/2023; P2100683, EXP 01/31/2024; P2106002, EXP 07/31/2024; R2200148, EXP 12/31/2024; R2201125, EXP 06/30/2025 b) P2003403, EXP 05/31/2023; b) P2005800, EXP 09/30/2023; P2101156, EXP 01/31/2024; P2105401, EXP 07/31/2024; R2200083, EXP 12/31/2024; R2201004, EXP 07/31/2025

More recalls by Amerisource Health Services Llc

View all recalls by this company →

Other recent Class II Drug recalls